Ignite Creation Date:
2024-05-05 @ 11:24 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01328249
Status:
COMPLETED
Last Update Posted:
2019-08-20
First Post:
2011-03-22
Brief Title:
Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2011-03-22
First Submit QC Date:
April 1 2011
Study First Post Date:
2011-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-09-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-08-09
Last Update Post Date:
2019-08-20
Last Update Post Date Type:
ACTUAL